Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?-Reference-Cited by-同舟云学术

Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?

Published:2022-09-27 Issue:1 Volume:131 Page:20-31
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Ong Sean¹²^ORCID,Chen Kenneth³⁴^ORCID,Grummet Jeremy⁵,Yaxley John⁶⁷⁸,Scheltema Matthijs J.⁹¹⁰,Stricker Phillip⁹¹⁰¹¹^ORCID,Tay Kae Jack⁴,Lawrentschuk Nathan¹²³¹²^ORCID

Affiliation:

1. EJ Whitten Foundation Prostate Cancer Research Centre Epworth HealthCare Melbourne Vic. Australia

2. Department of Surgery University of Melbourne Melbourne Vic. Australia

3. Division of Cancer Surgery Peter MacCallum Cancer Centre Melbourne Vic. Australia

4. Department of Urology Singapore General Hospital Singapore City Singapore

5. Department of Surgery Central Clinical School Monash University Melbourne Vic. Australia

6. The University of Queensland School of Medicine Brisbane QLD Australia

7. Wesley Urology Clinic Wesley Hospital Brisbane QLD Australia

8. Department of Urology Royal Brisbane and Women's Hospital Brisbane QLD Australia

9. St. Vincent's Prostate Cancer Research Centre Darlinghurst NSW Australia

10. Department of Urology St Vincents Hospital and Campus Sydney NSW Australia

11. Garvan Institute of Medical Research Darlinghurst NSW Australia

12. Department of Urology Royal Melbourne Hospital Melbourne Vic. Australia

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15883

Reference31 articles.

1. A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research

2. Focal Therapy in Primary Localised Prostate Cancer : The European Association of Urology Position in 2018

3. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

4. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

5. Edward SchaefferSS AntonarakisES ArmstrongAJet al.NCCN clinical practice guidelines in oncology (NCCN Guidelines®) prostate cancer2022. Version 4.2022:[1–197 pp.].2022. Available at:https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed 20 July 2022

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biopsy strategies in the era of mpMRI: a comprehensive review;Prostate Cancer and Prostatic Diseases;2024-09-04

2. Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm;BJUI Compass;2024-08-26

3. Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE‐IMMUNO study;BJU International;2024-08-05

4. MR-guided Focused Ultrasound Focal Therapy for Prostate Cancer;Magnetic Resonance Imaging Clinics of North America;2024-07

5. A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial;Cancers;2024-06-08